Causes of death in the first 3 months during the IFM 95-01 trial analyzed by treatment allocation*
Causes of death . | Total no. patients . | MP . | M-DEX . | DEX . | DEX-IFN . |
|---|---|---|---|---|---|
| Myeloma progression | 13 | 1 | 0 | 3 | 9 |
| Died unexpectedly at home; cause not known | 3 | 0 | 0 | 3 | 0 |
| Pyogenic infection when tumor load not immediately life threatening | 12 | 3 | 1 | 5 | 3 |
| Cardiac | 2 | 1 | 1 | 0 | 0 |
| Neurologic | 1 | 0 | 1 | 0 | 0 |
| Perforated diverticulum | 1 | 0 | 0 | 0 | 1 |
| Hemorrhage | 1 | 0 | 0 | 1 | 0 |
| Amyloidosis | 1 | 1 | 0 | 0 | 0 |
| MDS/secondary leukemia | 0 | 0 | 0 | 0 | 0 |
| Other cancer | 0 | 0 | 0 | 0 | 0 |
| Other causes | 4 | 0 | 0 | 0 | 1† |
Causes of death . | Total no. patients . | MP . | M-DEX . | DEX . | DEX-IFN . |
|---|---|---|---|---|---|
| Myeloma progression | 13 | 1 | 0 | 3 | 9 |
| Died unexpectedly at home; cause not known | 3 | 0 | 0 | 3 | 0 |
| Pyogenic infection when tumor load not immediately life threatening | 12 | 3 | 1 | 5 | 3 |
| Cardiac | 2 | 1 | 1 | 0 | 0 |
| Neurologic | 1 | 0 | 1 | 0 | 0 |
| Perforated diverticulum | 1 | 0 | 0 | 0 | 1 |
| Hemorrhage | 1 | 0 | 0 | 1 | 0 |
| Amyloidosis | 1 | 1 | 0 | 0 | 0 |
| MDS/secondary leukemia | 0 | 0 | 0 | 0 | 0 |
| Other cancer | 0 | 0 | 0 | 0 | 0 |
| Other causes | 4 | 0 | 0 | 0 | 1† |